The GLP-1 receptor agonist liraglutide attenuates atherosclerotic lesion development and enhances plaque stability in an ApoE-/- mouse model

被引：0
|
作者：
Dear, A. E. [1 ]
Gaspari, T. [1 ]
Welungoda, I. [1 ]
Widdop, R. E. [1 ]
Simpson, R. W. [1 ]
机构：
[1] Monash Univ, Melbourne, Vic 3004, Australia
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
780
引用
收藏
页码：S321 / S321
页数：1
相关论文
共 50 条
  • [31] The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
    Secher, Anna
    Jelsing, Jacob
    Baquero, Arian F.
    Hecksher-Sorensen, Jacob
    Cowley, Michael A.
    Dalboge, Louise S.
    Hansen, Gitte
    Grove, Kevin L.
    Pyke, Charles
    Raun, Kirsten
    Schaffer, Lauge
    Tang-Christensen, Mads
    Verma, Saurabh
    Witgen, Brent M.
    Vrang, Niels
    Knudsen, Lotte Bjerre
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (10): : 4473 - 4488
  • [32] Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update
    Vandemark, Collin
    Nguyen, Jimmy
    Zhao, Zhi-Qing
    MOLECULES, 2023, 28 (03):
  • [33] Liraglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity
    Gallwitz, B.
    DRUGS OF THE FUTURE, 2008, 33 (01) : 13 - 20
  • [34] Liraglutide 3 mg Treatment of Adiposity: GLP-1 Receptor Agonist as new Therapeutic Option
    Aberle, Jens
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (04): : 4 - 10
  • [35] Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats
    Yamada, Shohei
    Ogura, Yuji
    Inoue, Kazuho
    Tanabe, Jun
    Sugaya, Takeshi
    Ohata, Keiichi
    Nagai, Yoshio
    Natsuki, Yasunori
    Hoshino, Seiko
    Watanabe, Shiika
    Ichikawa, Daisuke
    Kimura, Kenjiro
    Shibagaki, Yugo
    Kamijo-Ikemori, Atsuko
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2022, 539
  • [36] GLP-1 receptor agonist, liraglutide, improves neovascularization by improving the function of endothelial progenitor cells
    Zheng, Chao
    Su, Yue
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
  • [37] Silencing of junctional adhesion molecule-like protein attenuates atherogenesis and enhances plaque stability in ApoE-/- mice
    Sun, Yu
    Guan, Juan
    Hou, Yunfeng
    Xue, Fei
    Huang, Wei
    Zhang, Wencheng
    Zhang, Yun
    Zhang, Cheng
    Yang, Jianmin
    CLINICAL SCIENCE, 2019, 133 (11) : 1215 - 1228
  • [38] Liver X receptor activation attenuates plaque formation and improves vasomotor function of the aortic artery in atherosclerotic ApoE-/- mice
    Chen, Jianghong
    Zhao, Li
    Sun, Dongdong
    Narsinh, Kazim
    Li, Chunhong
    Zhang, Zheng
    Qi, Shun
    Wei, Guangquan
    Li, Weijie
    Guo, Wenyi
    Cao, Feng
    INFLAMMATION RESEARCH, 2012, 61 (12) : 1299 - 1307
  • [39] Gremlin-1 Is an Inhibitor of Macrophage Migration Inhibitory Factor and Attenuates Atherosclerotic Plaque Growth in ApoE-/- Mice
    Mueller, Iris
    Schnberger, Tanja
    Schneider, Martina
    Borst, Oliver
    Ziegler, Melanie
    Seizer, Peter
    Leder, Christoph
    Mueller, Karin
    Lang, Michael
    Appenzeller, Florian
    Lunov, Oleg
    Buechele, Berthold
    Fahrleitner, Manuela
    Olbrich, Marcus
    Langer, Harald
    Geisler, Tobias
    Lang, Florian
    Chatterjee, Madhumita
    de Boer, Jan Freark
    Tietge, Uwe J. F.
    Bernhagen, Juergen
    Simmet, Thomas
    Gawaz, Meinrad
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (44) : 31635 - 31645
  • [40] Sulindac-derived retinoid X receptor-α modulator attenuates atherosclerotic plaque progression and destabilization in ApoE-/- mice
    Shen, Linghong
    Sun, Zhe
    Nie, Peng
    Yuan, Ruosen
    Cai, Zhaohua
    Wu, Caizhe
    Hu, Liuhua
    Jin, Shuxuan
    Zhou, Hu
    Zhang, Xiaokun
    He, Ben
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (14) : 2559 - 2572
12345